Skip to content
10-Q

Quarterly Report

AVANOS MEDICAL, INC. AVNS

0001606498-25-000091

← back to feed
Filed
May 6, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · Apr 29, 2025 46.24M sh
Cash And Equivalents Q1 2025 · Mar 31, 2025 $97M
Cash And Equivalents Q1 2025 · Dec 31, 2024 $107.7M
Current Liabilities Q1 2025 · Mar 31, 2025 $137.2M
Current Liabilities Q1 2025 · Dec 31, 2024 $165.9M
Total Liabilities Q1 2025 · Mar 31, 2025 $268.4M
Total Liabilities Q1 2025 · Dec 31, 2024 $325.7M
Current Assets Q1 2025 · Mar 31, 2025 $352.4M
Current Assets Q1 2025 · Dec 31, 2024 $393.4M
Total Assets Q1 2025 · Mar 31, 2025 $1.11B
Total Assets Q1 2025 · Dec 31, 2024 $1.15B
Stockholders Equity Q1 2025 · Dec 31, 2024 $828.5M
Stockholders Equity Q1 2025 · Mar 31, 2024 $1.23B
Shares Diluted Q1 2025 · Mar 31, 2024 46.7M sh
Stock Repurchased Q1 2025 · Mar 31, 2024 $9.1M
Capex Q1 2025 · Mar 31, 2024 $4.1M
Operating Cash Flow Q1 2025 · Mar 31, 2024 −$8M
Eps Diluted Q1 2025 · Mar 31, 2024 −$0.02
Eps Basic Q1 2025 · Mar 31, 2024 −$0.02
Sga Expense Q1 2025 · Mar 31, 2024 $83.6M
Rd Expense Q1 2025 · Mar 31, 2024 $7M
Net Income Q1 2025 · Mar 31, 2024 −$900K
Operating Income Q1 2025 · Mar 31, 2024 $4M
Gross Profit Q1 2025 · Mar 31, 2024 $94.8M
Cost Of Revenue Q1 2025 · Mar 31, 2024 $71.3M
Revenue Q1 2025 · Mar 31, 2024 $166.1M